LMDX News

Despite headwinds in the SPAC market, some small companies are abandoning their traditional public offering plans in favor of the IPO alternative. Early-stage alfalfa producer African Agriculture (AAGR) and preclinical drug developer Intrinsic Medical (INRX) are the latest IPO candidates to pursue public listings via SPAC mergers. Originally...read more

LumiraDx, a UK-based provider of point-of-care diagnostics including COVID-19 tests, withdrew its plans for an initial public offering on Wednesday. It originally filed in January 2021 with a proposed deal size of $100 million. The withdrawal follows the announcement of a merger agreement between LumiraDx and SPAC CA Healthcare Acquisition (CAHC). LumiraDx aims to...read more

CA Healthcare Acquisition, a blank check company targeting the healthcare industry, raised $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. The company is led by CEO and Chairman Larry Neiterman, who previously served as COO of the US consulting...read more

LumiraDx, a UK-based provider of point-of-care diagnostics including COVID-19 tests, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company aims to bring lab-comparable performance to the point-of-care in minutes on a single instrument with a low cost of ownership. In 2020, it developed SARS-CoV-2 antigen and antibody tests for...read more